StonvexLoading…
StonvexStonvexStonvexCore line items from RNST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.26B | $887.78M | $797.32M | $541.81M |
Operating Income | $226.73M | $244.97M | $177.19M | $211.31M |
Net Income | $181.27M | $195.46M | $144.68M | $166.07M |
EPS (Diluted) | $2.07 | $3.27 | $2.56 | $2.95 |
Total Assets | $26.75B | $18.03B | $17.36B | $16.99B |
Total Liabilities | $22.87B | $15.36B | $15.06B | $14.85B |
Cash & Equivalents | $1.07B | $1.09B | $801.35M | $575.99M |
Free Cash Flow OCF − CapEx | $237.75M | $92.77M | $126.92M | $559.21M |
Shares Outstanding | 94.64M | 63.57M | 56.14M | 55.95M |